Ignite Creation Date:
2025-12-24 @ 2:47 PM
Ignite Modification Date:
2025-12-26 @ 1:13 PM
Study NCT ID:
NCT06263959
Status:
RECRUITING
Last Update Posted:
2025-03-05
First Post:
2024-01-07
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Double-blind, Placebo-controlled Phase IIa Clinical Study to Evaluate the Safety and Efficacy of GST-HG131 Tablets in Patients With Chronic Hepatitis B
Sponsor:
Fujian Akeylink Biotechnology Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-12-26
Start Date Type:
ACTUAL
Primary Completion Date:
2025-04-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-05-01
Completion Date Type:
ESTIMATED
First Submit Date:
2024-01-07
First Submit QC Date:
None
Study First Post Date:
2024-02-16
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-03
Last Update Post Date:
2025-03-05
Last Update Post Date Type:
ACTUAL